Filters
Results 1 - 10 of 39293
Results 1 - 10 of 39293.
Search took: 0.055 seconds
| Sort by: date | relevance |
No abstract available
Source
Fuks, L. (ed.) (Institute of Nuclear Chemistry and Technology, Warsaw (Poland)); Institute of Nuclear Chemistry and Technology, Warsaw (Poland); 75 p; ISBN 978-83-909690-9-1; 
; 2009; p. 66; 5. National Conference on Radiochemistry and Nuclear Chemistry; 5. Krajowa Konferencja Radiochemii i Chemii Jadrowej; Cracow-Przegorzaly (Poland); 24-27 May 2009; Also available from Institute of Nuclear Chemistry and Technology; 3 refs.
; 2009; p. 66; 5. National Conference on Radiochemistry and Nuclear Chemistry; 5. Krajowa Konferencja Radiochemii i Chemii Jadrowej; Cracow-Przegorzaly (Poland); 24-27 May 2009; Also available from Institute of Nuclear Chemistry and Technology; 3 refs.
[en] Calculations of complete data for n+99Tc reaction in En=0.01-20 MeV region are given in this paper. The calculated σtot, σnon, σel, σn,γ, σn,n', σn,p, σn,α and σn,nα are good agreement with experimental data
Source
Liu Tingjin; Zhuang Youxiang (eds.); China Nuclear Data Center, Beijing (China); China Nuclear Information Centre, Beijing (China); 90 p; Aug 2001; p. 28-29; ISBN 7-89999-840-9;
[en] Certain problems in microbiological investigation of radiopharmaceuticals are presented. A sterility test in accordance with the pharmacopoeias normally last 14 days. This period however is too long for 90Mo- 99mTc generators ( t1/2= 6.02). For this reason, it is permitted to use the product before the sterility test has been completed. (author)
Source
Kovacevic, M. (ed.) (Institut za Nuklearne nauke VINCA, Belgrade (Yugoslavia)); 392 p; ISBN 86-80055-70-0; ; 1995; p. 367-369; Institut za Nuklearne nauke VINCA; Belgrade (Yugoslavia); 18. Yugoslav symposium on radiation protection; XIX Jugoslovenski simpozijum za zastitu od zracenja; Becici (Yugoslavia); 24-26 May 1995
; 1995; p. 367-369; Institut za Nuklearne nauke VINCA; Belgrade (Yugoslavia); 18. Yugoslav symposium on radiation protection; XIX Jugoslovenski simpozijum za zastitu od zracenja; Becici (Yugoslavia); 24-26 May 1995
[en] Dimercaptosuccinic acid (DMSA) is an analog of dimercaprol used as metal chelating moiety in variety of conditions. In nuclear medicine itself two types of Tc-99m DMSA complexes are used, trivalent and pentavalent forms. In this review, we have discussed the mechanism of uptake of both complexes as well as diagnostic and therapeutic application in a clinical scenario
Journal
Indian Journal of Nuclear Medicine; ISSN 0972-3919; ; v. 30(4); p. 295-302
; v. 30(4); p. 295-302
| 1 | 2 | 3 | Next |